Skip to main content
Screener/Healthcare/Biotechnology

RPRX — Royalty Pharma plc

NASDAQ
$50.60+0.42 (+0.84%)
Large CapHealthcareLow BetaMost Profitable
$32.15
$51.65
$50.50
$51.17
EPS (TTM)$1.24
P/E Ratio40.81
Dividend Yield1.78%
Market Cap$21.52B
Volume1.26M
Prev Close$50.20
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$631.0M$295.0M$0.000.0%46.8%
Q4 '25$622.0M$214.2M$0.50100.0%34.4%
Q3 '25$609.3M$288.2M$0.67100.0%47.3%
Q2 '25$578.7M$30.2M$0.07100.0%5.2%
Q1 '25$568.2M$238.3M$0.55100.0%41.9%
Q4 '24$593.6M$208.2M$0.47100.0%35.1%
Q3 '24$564.7M$544.0M$0.92100.0%96.3%
Q2 '24$537.3M$102.0M$0.23100.0%19.0%
Get Your Daily Market Recap